Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

SyntheticMR

1.31 SEK

-1.13 %

Less than 1K followers

SYNT

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-1.13 %
-1.87 %
-2.96 %
-47.39 %
-62.46 %
-72.07 %
-95.97 %
-96.00 %
-41.04 %

SyntheticMR is a medical technology company that is active in the development of analysis and imaging methods. The technology is mainly used for magnetic resonance imaging (MRI) in healthcare. The technology is based on a quantification-based method that aims to increase the efficiency and quality of MRI examinations. The company was founded in 2007 and is headquartered in Linköping.

Read more
Market cap
78.02M SEK
Turnover
349.1 SEK
Revenue
55.67M
EBIT %
-32.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
9/1
2026

Extraordinary general meeting '25

6/2
2026

Annual report '25

12/5
2026

Interim report Q1'26

All
Press releases
3rd party
ShowingAll content types
Regulatory press release1 hour ago

Report from the extraordinary general meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release1 hour ago

Kommuniké från extra bolagsstämma i SyntheticMR AB (publ)

SyntheticMR
Regulatory press release12/18/2025, 8:01 AM

Notice of extra general meeting in SyntheticMR AB (publ)

SyntheticMR

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release12/18/2025, 8:00 AM

Kallelse till extra bolagsstämma i SyntheticMR AB (publ)

SyntheticMR
Regulatory press release12/17/2025, 10:03 PM

SyntheticMR AB resolves on a fully secured rights issue of approximately SEK 32.8 million

SyntheticMR
Regulatory press release12/17/2025, 10:00 PM

SyntheticMR AB beslutar om fullt säkerställd företrädesemission om cirka 32,8 miljoner kronor

SyntheticMR
Third party research12/2/2025, 8:25 AM

Synthetic MR: Svag försäljning sätter press på kassan - Analysguiden

SyntheticMR redovisade ett svagt tredje kvartal där omsättningen sjönk med 7 procent och resultatet tyngdes av en större nedskrivning kopplad till äldre SyMRI-avtal. Försäljningen utvecklades positivt i USA och Europa men föll kraftigt i APAC, samtidigt...

SyntheticMR
Press release12/2/2025, 8:05 AM

Analysguiden: ANALYS SyntheticMR: Svag försäljning sätter press på kassan

SyntheticMR
Regulatory press release11/28/2025, 7:00 AM

SyntheticMR AB: Interim report July - September 2025

SyntheticMR
Regulatory press release11/28/2025, 7:00 AM

SyntheticMR AB: Delårsrapport juli - september 2025

SyntheticMR
Regulatory press release11/25/2025, 6:07 PM

SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025

SyntheticMR
Regulatory press release11/25/2025, 6:04 PM

SyntheticMR AB (publ) senarelägger delårsrapport för tredje kvartalet 2025

SyntheticMR
Regulatory press release11/22/2025, 2:53 PM

Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)

SyntheticMR
Regulatory press release11/22/2025, 2:52 PM

Marcel Warntjes avgår ur styrelsen för SyntheticMR AB (publ)

SyntheticMR
Press release10/29/2025, 7:50 AM

SyntheticMR AB: Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR

SyntheticMR
Press release10/29/2025, 7:49 AM

SyntheticMR AB: Valberedning utsedd inför årsstämman 2026 i SyntheticMR

SyntheticMR
Regulatory press release9/1/2025, 6:18 AM

Lena Åredal Assumes Role as CEO of SyntheticMR AB (publ)

SyntheticMR
Regulatory press release9/1/2025, 6:17 AM

Lena Åredal tillträder som ny VD för SyntheticMR AB (publ)

SyntheticMR
Regulatory press release8/26/2025, 6:07 AM

SyntheticMR AB: Interim report April- June 2025

SyntheticMR
Regulatory press release8/26/2025, 6:05 AM

SyntheticMR AB: Delårsrapport april - juni 2025

SyntheticMR
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.